Mostrando 8 resultados de: 8
Filtros aplicados
Publisher
Pharmacogenomics(3)
Clinical Therapeutics(1)
Expert Opinion on Drug Metabolism and Toxicology(1)
Genome Research(1)
Nature Communications(1)
Challenges and Opportunities for Clinical Pharmacogenetic Research Studies in Resource-limited Settings: Conclusions From the Council for International Organizations of Medical Sciences–Ibero-American Network of Pharmacogenetics and Pharmacogenomics Meeting
ArticleAbstract: Purpose: The symposium Health and Medicines in Indigenous Populations of America was organized by thPalabras claves:CIOMS-RIBEF, clinical research, pharmacogenetics, resource-limited settingsAutores:Adrián LLerena, Diwakar S., Enrique Terán, Galaviz-Hernandez C., Gil J.P., Isabel Hernández, Lara-Riegos J., Molina-Guarneros J.A., Moya G.E., Nair S., Penãs-Lledó E.M., Rägo L., Ramírez-Roa R., Sosa-Macías M.G., Tarazona-Santos E.M., Verde I.Fuentes:googlescopusAuthor Correction: Whole-genome sequencing of 1,171 elderly admixed individuals from Brazil (Nature Communications, (2022), 13, 1, (1004), 10.1038/s41467-022-28648-3)
OtherAbstract: The original version of this Article contained an error in the title, which was previously incorrectPalabras claves:Autores:Araújo N.M., Borda V., Bozoklian D., Buzzo J.L., Cáceres O., Castelli E.C., Castro C.F.B., Ceroni J.R.M., da Silva Simões C.E., da Silva Souza A., de Carvalho D.L., de Souza Andrade H., Dean M., dos Santos Brito Silva N., Duarte Y.A.O., Galante P.A.F., Guio H., Guryev V., Horta B.L., Karp T., Lima-Costa M.F., Magalhães W.C.S., Mauricio L. Barreto, Mendes-Junior C.T., Mercuri R.L.V., Meyer D., Miller T.L.A., Mingroni-Netto R.C., Naslavsky M.S., Nonaka R., Nunes K., Passos M.R.S., Passos-Bueno M.R., Rego F.O., Rojas C.P., Sanchez C., Scliar M.O., Tarazona-Santos E.M., Wang J.Y.T., Yamamoto G.L., Zatz M., Zverinova S.Fuentes:scopusGenetic structure of pharmacogenetic biomarkers in Brazil inferred from a systematic review and population-based cohorts: a RIBEF/EPIGEN-Brazil initiative
ArticleAbstract: We present allele frequencies involving 39 pharmacogenetic biomarkers studied in Brazil, and their dPalabras claves:Autores:Adrián LLerena, Andrade P.X.C., Aquino M.M., Céspedes-Garro C., Horta B.L., Kehdy F.S.G., Lima-Costa M.F., Mauricio L. Barreto, Pereira A.C., Rodrigues-Soares F., Sampaio-Coelho J., Tarazona-Santos E.M., Zolini C.Fuentes:scopusEPIGEN-Brazil Initiative resources: A Latin American imputation panel and the Scientific Workflow
ArticleAbstract: EPIGEN-Brazil is one of the largest Latin American initiatives at the interface of human genomics, pPalabras claves:Autores:Alvim I.O., Araujo G.S., Araújo N.M., Borda V., Costa G.N.O., Gouveia M.H., Horta B.L., Kehdy F.S.G., Leal T.P., Lima-Costa M.F., Machado M., Magalhães W.C.S., Mauricio L. Barreto, Moreira R.G., Pereira A.C., Rodrigues M.R., Rodrigues-Soares F., Sant Anna H.P., Santolalla M.L., Scliar M.O., Soares-Souza G.B., Tarazona-Santos E.M., Viriato P.J.S., Zamudio R., Zolini C.Fuentes:scopusInterethnic variability of CYP2D6 alleles and of pbkp_redicted and measured metabolic phenotypes across world populations
ReviewAbstract: Introduction: The frequency of CYP2D6 alleles, related to either a lack of or increased enzymatic acPalabras claves:CYP2D6, CYP2D6∗10, CYP2D6∗17, CYP2D6∗29, CYP2D6∗4, CYP2D6∗41, ethnicity, Poor metabolizers, population pharmacogenetics, Ultrarapid metabolizersAutores:Adrián LLerena, Humberto Fariñas, Naranjo M.E.G., Penãs-Lledó E.M., Rodrigues-Soares F., Tarazona-Santos E.M.Fuentes:scopusPharmacogenetics and ethnicity: relevance for clinical implementation, clinical trials, pharmacovigilance and drug regulation in Latin America
Conference ObjectAbstract: Congress of Pharmacogenetics and Personalized Medicine. Ethnicity, clinical implementation and regulPalabras claves:clinical trials, Latin American populations, metabolic genotypes, Metabolic phenotypes, native populations, pharmacogenetics, pharmacovigilanceAutores:Adrián LLerena, Altamirano C., Céspedes-Garro C., Enrique Terán, Francisco J.López Hernández, Galaviz-Hernandez C., Humberto Fariñas, Jung-Cook H., López-López M., MARTHA FORS, Martha M. Fors-López, Moya G.E., Ramirez R., Remírez D., Sosa-Macías M.G., Tarazona-Santos E.M., William F. WatersFuentes:googlescopusPharmacogenetics research in Brazil: a systematic review
ReviewAbstract: Aim: Pharmacogenomics (PGx) is a rising scientific area in many countries, such as Brazil. ObjectivePalabras claves:Brazil, pharmacogenetics, Population geneticsAutores:Adrián LLerena, Andrade P.X.C., Céspedes-Garro C., Nobre I.H., Rodrigues-Soares F., Sampaio-Coelho J., Scudeler M.M., Tarazona-Santos E.M., Torres-Loureiro S.Fuentes:scopusPopulation pharmacogenetics of Ibero-Latinoamerican populations (MESTIFAR 2014)
Conference ObjectAbstract: MESTIFAR 2014 28-30 November 2014, Panama City, Panama The CEIBA consortium was created within the IPalabras claves:Cytochrome p450, drug metabolism, genome-wide analyses, Ibero-Americans populations, Metabolic phenotypes, next-generation sequencing, pharmacogenetics, Population geneticsAutores:Acosta H., Adrián LLerena, Céspedes-Garro C., Enrique Terán, Galaviz-Hernandez C., Moya G.E., Penãs-Lledó E.M., Ramirez R., Sosa-Macías M.G., Tarazona-Santos E.M.Fuentes:googlescopus